Deadline: 23-Jan-2026
The LRI Flagship Grant supports high-impact research projects addressing leprosy, including prevention, treatment, and social impact. Researchers and organisations can receive funding to generate new evidence, inform policy, and improve outcomes for affected communities, advancing global efforts to control and eliminate leprosy.
Overview
The Leprosy Research Initiative (LRI) Flagship Grant is a premier funding opportunity for researchers and organisations working on high-impact leprosy research. The grant focuses on supporting ambitious studies and interventions that address critical gaps in understanding leprosy, its transmission, treatment, and social consequences.
The programme aims to generate actionable knowledge that can inform health policy, strengthen care, and reduce the burden of leprosy globally. It reflects LRI’s commitment to scientific excellence, collaboration, and sustained focus on neglected tropical diseases.
Purpose and Objectives
The LRI Flagship Grant is designed to:
-
Support research that advances understanding of leprosy biology, transmission, and treatment
-
Fund interventions that improve prevention, diagnosis, rehabilitation, and patient outcomes
-
Address social, cultural, and policy-related aspects affecting people living with leprosy
-
Inform global and national health strategies and advocacy efforts
-
Promote collaboration among researchers, institutions, and affected communities
Who Can Apply
Eligible Applicants
-
Individual researchers or research teams
-
Academic or non-governmental organisations actively engaged in leprosy research
-
Groups capable of conducting rigorous, high-quality studies with potential global impact
Key Considerations
Applicants should demonstrate:
-
Scientific rigour and clear research methodology
-
Relevance to pressing challenges in leprosy control or care
-
Capacity to generate evidence that informs policy or practice
-
Potential for substantial impact on affected communities
Types of Research Supported
The LRI Flagship Grant encourages projects that tackle critical knowledge gaps and practical challenges. Supported research areas include:
-
Biomedical research on disease mechanisms, transmission, or treatment
-
Clinical trials or intervention studies
-
Epidemiology and public health strategies
-
Social, cultural, and policy-related research addressing stigma and patient support
-
Innovative tools or approaches to improve diagnosis, care, or rehabilitation
Funding and Grant Support
Selected applicants receive:
-
Financial support to undertake comprehensive studies or interventions
-
Resources to facilitate robust data collection, analysis, and dissemination
-
Opportunities to engage in collaboration with international researchers and organisations
The funding is intended to enable projects that are substantial in scale and capable of influencing practice and policy.
Application Requirements
Applicants are encouraged to provide clear and detailed information on:
-
Research objectives and rationale
-
Methodology and expected outcomes
-
Alignment with global efforts to eliminate leprosy
-
Potential impact on patients, communities, and health systems
-
Plans for dissemination and translation of findings
Projects should demonstrate both scientific credibility and real-world applicability.
Why the LRI Flagship Grant Matters
The grant plays a critical role in advancing leprosy research and care:
-
Enables high-quality research in a neglected disease area
-
Supports evidence-based strategies to reduce disease burden
-
Strengthens collaboration among researchers, institutions, and communities
-
Enhances global understanding of biomedical and social aspects of leprosy
-
Contributes to policy development and advocacy efforts
By funding innovative, impactful research, the grant supports both scientific discovery and tangible improvements in patient care.
Tips for a Strong Application
-
Clearly define research questions and objectives
-
Demonstrate methodological rigor and feasibility
-
Highlight potential policy or practice impact
-
Show awareness of social and cultural dimensions of leprosy
-
Emphasize alignment with global leprosy elimination goals
-
Outline a clear plan for dissemination and stakeholder engagement
Common Mistakes to Avoid
-
Proposing projects without clear relevance to leprosy control or care
-
Failing to provide a detailed and feasible methodology
-
Underestimating the practical or social implications of research
-
Ignoring the potential for policy or community impact
-
Overlooking the importance of collaboration or stakeholder engagement
Frequently Asked Questions (FAQ)
Who can apply for the LRI Flagship Grant?
Individual researchers, research teams, and organisations actively engaged in leprosy research.
What types of research are eligible?
Biomedical, clinical, epidemiological, social, policy, and intervention-focused research addressing leprosy.
How does the grant support projects?
Through financial resources to conduct studies, interventions, data collection, and dissemination activities.
Are collaborative projects encouraged?
Yes. Collaboration across institutions, countries, and communities is highly valued.
What is the expected impact of funded projects?
Projects should generate new evidence, inform policy, improve care, and contribute to reducing leprosy’s burden.
Is the grant only for biomedical research?
No. The grant also supports social, cultural, and policy-focused research with practical implications.
How should applicants demonstrate alignment with global goals?
By showing how the research contributes to leprosy control, elimination strategies, or improved health outcomes for affected populations.
Conclusion
The LRI Flagship Grant offers a strategic platform for researchers and organisations to advance high-impact work in leprosy research, prevention, and care. By funding projects that generate robust evidence, inform policy, and improve outcomes, the programme strengthens global efforts to combat leprosy and supports innovative approaches that benefit both patients and the wider health community.
For more information, visit LRI.